Does time to esophagectomy following neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma affect outcomes?

OBJECTIVES: Neoadjuvant immunochemotherapy (nICT) is a novel pattern for locally advanced esophageal squamous cell carcinoma (ESCC), and the time to surgery (TTS) is recommended as 4-6 weeks. However, there were some patients with prolonged TTS(> 6 weeks). This study aimed to explore whether prol...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Zhi-Nuan, Huang, Zhixin, Weng, Kai, Lin, Jihong, Kang, Mingqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614210/
https://www.ncbi.nlm.nih.gov/pubmed/36311738
http://dx.doi.org/10.3389/fimmu.2022.1036396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614210/
https://www.ncbi.nlm.nih.gov/pubmed/36311738
http://dx.doi.org/10.3389/fimmu.2022.1036396

Ejemplares similares